Metbleo 15IU Injection: Effective Hormone Replacement Therapy

Uses:

• Hodgkin's lymphoma;
• Non-Hodgkin's lymphoma;
• Testicular cancer;
• Some types of lung cancer.

Therapeutic effects:

• Inhibits cancer cell growth and proliferation by interfering with DNA replication and transcription;
• Slows or stops the growth of cancer cells, leading to their destruction;
• Helps to shrink tumours and improve symptoms in cancer patients.

Interaction with other drugs:

• Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products;
• Certain medications may interact with Metbleo 15IU Injection and reduce effectiveness by causing undesirable side effects.

Storage:

• Store according to the manufacturer's instructions or as directed by a healthcare provider;
• In general, the medication should be stored at room temperature, between 20°C and 25°C (68°F and 77°F), in a dry place, away from light and moisture;
• Keep in its original packaging until ready to use;
• Store out of the reach of children and pets;
• Unused or expired medication should be properly disposed of in accordance with local regulations or guidelines.

Administration:

• Administered through injection by a healthcare provider in a hospital or clinical setting;
• The dosage and frequency of administration will vary depending on the type of cancer being treated, the patient's age and weight, and other factors;
• Should not be taken orally, as it is not absorbed well through the gastrointestinal tract and may cause serious side effects if ingested.

Safety advisories:

• Pregnancy: not safe for pregnant women as it may cause foetal harm;
• Breast feeding: it is not known whether it is excreted in human milk or not;
• Lungs: use with caution in patients with pre-existing lung disease or a history of lung surgery;
• Liver: regular monitoring of liver function tests is recommended;
• Alcohol: it is generally recommended that patients taking Metbleo 15IU Injection avoid or limit their alcohol intake;
• Driving: may cause side effects such as fatigue, dizziness, or blurred vision that can impair a patient's ability to drive or operate machinery safely.

Side effects:

• Serious: fever, chills, fatigue, loss of appetite, nausea and vomiting, mouth sores, skin rash or itching, hair loss, cough or shortness of breath, low blood cell counts;
• Serious: interstitial pneumonitis (inflammation of lung linings), pulmonary fibrosis, liver toxicity, kidney toxicity, allergic reactions, increased risk of infections.

FAQs:

• Q 1. Can Metbleo 15IU Injection cause hair loss?
  • Yes, Metbleo 15IU Injection can cause hair loss, although it is not a common side effect.
• Q 2. Can Metbleo 15IU Injection be given to children?
  • Yes, Metbleo 15IU Injection can be given to children, but the dose and administration frequency may differ from adults.
• Q 3. Can Metbleo 15IU Injection be used alone to treat cancer?
  • Metbleo 15IU Injection is rarely used alone to treat cancer. It is typically used in combination with other chemotherapy drugs or radiation therapy as part of a comprehensive treatment plan.
• Q 4. Can Metbleo 15IU Injection cause fertility problems?
  • Yes, Metbleo 15IU Injection can cause fertility problems in both men and women.
• Q 5. Can Metbleo 15IU Injection cause skin reactions?
  • Yes, Metbleo 15IU Injection can cause skin reactions such as rash or redness at the injection site.
• Q 6. Can Metbleo 15IU Injection be given at home?
  • A healthcare professional typically administers Metbleo 15IU Injection in a hospital or clinic setting. However, in some cases, it may be possible for patients to receive this at home through a home health agency.
• Q 7. Can Metbleo 15IU Injection cause hearing loss?
  • Yes, Metbleo 15IU Injection can cause hearing loss as a side effect, particularly in patients who receive high doses or long-term treatment.
• Q 8. How does the body metabolize Metbleo 15IU Injection?
  • Metbleo 15IU Injection is primarily metabolized by the liver and excreted through the kidneys.
• Q 9. Can Metbleo 15IU Injection be given to patients with kidney problems?
  • Metbleo 15IU Injection is primarily excreted through the kidneys, so patients with kidney problems may be at increased risk of side effects from the drug. However, the dose may be adjusted in patients with kidney problems to reduce this risk.

Fact box:

• Molecule name: Bleomycin;
• Therapeutic class: Anticancer;
• Pharmacological class: Antineoplastic.

Tags: metbleo, injection, 15iu, medical-product, pharmacy, healthcare, drug, treatment